Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$895M |
| 2 |
Analog Devices
ADI
|
+$737M |
| 3 |
Zai Lab
ZLAB
|
+$472M |
| 4 |
NetEase
NTES
|
+$465M |
| 5 |
Cisco
CSCO
|
+$440M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.48B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$898M |
| 3 |
Procter & Gamble
PG
|
+$567M |
| 4 |
Oracle
ORCL
|
+$478M |
| 5 |
Capital One
COF
|
+$459M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.29% |
| 2 | Financials | 13.39% |
| 3 | Healthcare | 12.62% |
| 4 | Consumer Discretionary | 12.44% |
| 5 | Industrials | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3751
Carter Bankshares
CARE
$792M
| $163K | ﹤0.01% |
+11,442
| New | +$141K |
|
|
SURF
3752
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $163K | ﹤0.01% |
21,577
+3,990
| +23% | +$25.5K |
|
|
SNCR
3753
DELISTED
Synchronoss Technologies
SNCR
| $161K | ﹤0.01% |
7,435
+260
| +4% | +$6.38K |
|
|
WIMI
3754
WiMi Hologram Cloud
WIMI
$23.9M
| $161K | ﹤0.01% |
3,912
+820
| +27% | +$34.5K |
|
3755
Goldgroup Mining Inc.
GORO
$165M
| $160K | ﹤0.01% |
101,621
+3,338
| +3% | +$6.34K |
|
|
BDSI
3756
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $160K | ﹤0.01% |
44,510
+7,209
| +19% | +$27.2K |
|
3757
Graham Corp
GHM
$1.23B
| $157K | ﹤0.01% |
12,656
+440
| +4% | +$5.68K |
|
|
PRVB
3758
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $157K | ﹤0.01% |
24,658
+2,313
| +10% | +$14.9K |
|
3759
GCM Grosvenor
GCMG
$816M
| $155K | ﹤0.01% |
+13,471
| New | +$146K |
|
3760
PureCycle Technologies
PCT
$1.45B
| $155K | ﹤0.01% |
11,699
+2,877
| +33% | +$43.4K |
|
3761
CytomX Therapeutics
CTMX
$723M
| $154K | ﹤0.01% |
30,175
+4,850
| +19% | +$26K |
|
|
ESPR
3762
DELISTED
Esperion Therapeutics
ESPR
| $153K | ﹤0.01% |
12,667
+2,037
| +19% | +$29.7K |
|
|
KDNY
3763
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $153K | ﹤0.01% |
11,992
+1,512
| +14% | +$19.9K |
|
3764
First Bank
FRBA
$468M
| $152K | ﹤0.01% |
+10,773
| New | +$144K |
|
|
CRON
3765
Cronos Group
CRON
$1.05B
| $149K | ﹤0.01% |
26,286
+392
| +2% | +$2.66K |
|
3766
Altimmune
ALT
$597M
| $147K | ﹤0.01% |
12,940
+2,502
| +24% | +$30.4K |
|
|
NEUE
3767
DELISTED
NeueHealth
NEUE
| $147K | ﹤0.01% |
+226
| New | +$199K |
|
3768
Limbach Holdings
LMB
$919M
| $146K | ﹤0.01% |
22,064
+773
| +4% | +$6.32K |
|
3769
Kiniksa Pharmaceuticals
KNSA
$5.93B
| $145K | ﹤0.01% |
12,736
+1,751
| +16% | +$22.8K |
|
3770
Aterian
ATER
$5.49M
| $144K | ﹤0.01% |
+1,104
| New | +$122K |
|
3771
CBAK Energy Technology Ltd
CBAT
$44.1M
| $144K | ﹤0.01% |
61,939
+11,020
| +22% | +$36.6K |
|
3772
Culp Inc
CULP
$43.7M
| $144K | ﹤0.01% |
11,204
+390
| +4% | +$5.48K |
|
|
STKL
3773
DELISTED
SunOpta
STKL
| $143K | ﹤0.01% |
16,063
+247
| +2% | +$2.5K |
|
|
NVVE
3774
DELISTED
Nuvve Holding Corp
NVVE
| – | – |
0
| – | – |
|
3775
Lineage Cell Therapeutics
LCTX
$279M
| $140K | ﹤0.01% |
55,643
+11,196
| +25% | +$28.7K |
|
Similar funds
Invesco's Q3 2021 Portfolio in Review
As of Q3 2021, Invesco held 4,110 positions worth $395B, down 2.9% from $407B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Invesco's Q3 2021 filing shows 151 new, 2,106 increased, 1,588 reduced and 95 closed positions. Its largest new stake was GXO Logistics: 973,368 shares worth $76.4M. The largest sale was Alibaba, an estimated $1.48B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- Invesco's largest Q3 2021 buy was GXO Logistics: 973,368 shares worth $76.4M.
- Invesco added most to Salesforce in Q3 2021, an estimated $895M increase.
- Invesco's biggest Q3 2021 reduction was Alibaba, cutting an estimated $1.48B.
- Invesco fully exited Maxim Integrated Products in Q3 2021, selling an estimated $898M.
- Invesco's ten largest holdings make up 11% of its $395B portfolio in Q3 2021.
- Invesco opened 151 new positions and closed 95 in Q3 2021.
- Invesco's portfolio value fell 2.9% quarter-over-quarter to $395B.
Based on Invesco's 13F filing for Q3 2021, filed 15 Nov 2021.